|
Just (Dr.) Monica@pkpd-babe.bsky.social |
“From a more practical standpoint, the modest benefits would likely not be questioned by patients, clinicians, or payers if amyloid antibodies were low risk, inexpensive, and simple to administer. However, they are none of these.”
jamanetwork.com/journals/jam...
#MedSky #Neuroscience #Dementia 🧪 🛟
1 replies 15 reposts 27 likes
